His career is focused on clinical and physiologic research of esophageal diseases and he is currently NIH funded to study the pathogenesis of GERD and Dysphagia. He has also been involved in the development of new technologies for diagnosis and treatment of GERD. In addition, he has been the primary investigator on a number of Industry funded projects ranging from investigator initiated physiologic studies to clinical trials involving new antisecretory medications and medical devices (Phase II, III and IV).